Overview
Compare with Freight Technologies, Inc., Vantage Corp (Singapore) or Singularity Future Technology Ltd., or pick any stock.
- TickerQNME on Nasdaq1
- IndustryArrangement of Transportation of Freight & Cargo1
- HeadquartersItasca, Illinois1
- Incorporated inNV3
- Business address1475 Thorndale Ave Suite A, Itasca, Il 601433
- Filer category, Emerging growth company3
See how the biggest companies compare on our leaderboards
Our business currently consists of three principal areas of focus: (i) our established, revenue-generating pharmaceutical distribution operations through Hupan Pharmaceutical; (ii) our recently initiated strategic focus on quantum-related and certain other advanced technology activities, which remains in the development and evaluation stage and has not generated revenue as of the date of this report; and (iii) our recently initiated efforts to provide dedicated AI compute capacity and managed inference services, which remain in the preliminary stage and have not resulted in executed customer contracts or generated revenue as of the date of this report.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
56.7%Gross margin2
-174.2%Operating margin2
-162.1%Net margin2
111.8%Revenue growth, 20262
-135.4%Return on equity2
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Crossborder Airfreights Solutions brought in 52% of the revenue Quanome Technologies, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Crossborder Airfreights Solutions | $10.4M | $9.2M |
| Cross Border Ocean Freights Solutions | $7.9M | $5.8M |
| Distribution Of Pharmaceutical Products | $2.8M |
Regions
Asia brought in 83% of the revenue Quanome Technologies, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| Asia | $13.1M | $14.8M |
| United States | $5.2M | $3.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue43¢$2.5M
- Other costs55¢$3.2M
- Income tax2¢$91.7K
Out of $5.9M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Revenue | $5.9M | $2.8M |
| Cost of revenue | $2.5M | $1.2M |
| Gross profit | $3.3M | $1.6M |
| Selling expenses | $2.6M | $393.3K |
| General and administrative expenses | $5.7M | $2.6M |
| Provision of allowance for expected credit loss on accounts receivable | $58.8K | $32.8K |
| Write-off of supplier advance | 20.0M CNY | |
| Provision of allowance for expected credit loss on loan receivable | $2.3M | |
| Total operating expenses | $13.5M | $3.0M |
| Loss from operations | -$10.2M | -$1.5M |
| Other income, net | $295.3K | $33.2K |
| Interest expense | -$149.7K | -$229.3K |
| Total other income (expense) | $145.6K | -$196.0K |
| Loss before income taxes | -$10.0M | -$1.7M |
| Income tax expense | $91.7K | $212.3K |
| Net loss from continuing operations | -$10.1M | -$1.9M |
| Loss from discontinued operation before the sale of ABL Chicago | -$1.9M | -$3.3M |
| Gain on sale of ABL Chicago | $2.6M | |
| Net income (loss) from discontinued operation | $654.4K | -$3.3M |
| Net loss | -$9.5M | -$5.2M |
| Foreign currency translation income | $472.5K | $9.3K |
| Comprehensive loss attributable to the Company | -$9.0M | -$5.2M |
| Continuing operations (in Dollars per share) | -$0 | -$0 |
| Discontinued operations, net of tax (in Dollars per share) | $0 | -$0 |
| Weighted Average Shares Outstanding basic (in Shares) | 25.7M shares | 7.6M shares |
| Weighted Average Shares Outstanding diluted (in Shares) | 25.7M shares | 7.6M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash | $670.3K | $4.8M | |
| Accounts receivable, net of credit loss allowance of $95,494 and $33,039 | $1.1M | $1.4M | |
| Note receivable | $65.2K | ||
| Prepaid expense, deposit and other receivable, net | $1.3M | $222.0K | |
| Inventories, net | $196.6K | $96.5K | |
| Right of return asset | $501.4K | $141.7K | |
| Current assets from discontinued operation | $3.5M | ||
| Total current assets | $11.0M | $10.3M | |
| Property and equipment at cost, net of accumulated depreciation | $191.1K | $160.6K | |
| Intangible assets, net | $280.0K | $365.4K | |
| Right of use operating lease assets, net | $159.2K | $271.3K | |
| Deposit | $4.3K | $38.9K | |
| Non-current assets from discontinued operation | $3.3M | ||
| Total non-current assets | $634.6K | $4.1M | |
| TOTAL ASSETS | $11.7M | $14.4M | |
| Accounts payables | $650.6K | $1.0M | |
| Accrued liabilities and other payables | $2.0M | $1.2M | |
| Current portion of obligations under operating leases | $43.7K | $108.8K | |
| Loan payable, current | $187.8K | $262.9K | |
| Contract liabilities | $72.3K | $15.4K | |
| Income tax payable | $404.9K | $233.1K | |
| Convertible debts - current | $85.1K | $910.7K | |
| Refund liabilities | $849.8K | $77.2K | |
| Current liabilities from discontinued operation | $5.9M | ||
| Total current liabilities | $4.5M | $9.7M | |
| Loan payable, non-current | $46.3K | ||
| Deferred tax liabilities | $83.1K | ||
| Obligations under operating leases, non-current | $115.5K | $150.8K | |
| Non-current liabilities from discontinued operation | $1.7M | ||
| Total non-current liabilities | $161.8K | $1.9M | |
| TOTAL LIABILITIES | $4.6M | $11.6M | |
| Common stocks, $0.0001 par value, 200,000,000 shares authorized, 34,427,559 and 10,500,000 issued and outstanding as of June 30, 2026 and 2025, respectively | $3.4K | $1.1K | |
| Subscription receivable | -$1.4M | ||
| Additional paid-in capital | $22.7M | $8.1M | |
| Statutory reserve | $63.4K | $63.4K | |
| Deficits | -$14.8M | -$5.3M | |
| Accumulated other comprehensive income | $484.8K | $12.3K | |
| Total equity | $7.0M | $2.8M | $639.8K |
| TOTAL LIABILITIES AND EQUITY | $11.7M | $14.4M | |
| Accounts receivable, net of credit loss allowance | $95.5K | $33.0K | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 200.0M shares | 200.0M shares | |
| Common stock, shares issued (in Shares) | 34.4M shares | 10.5M shares | |
| Common stock, shares outstanding (in Shares) | 34.4M shares | 10.5M shares |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash | $670.3K | $4.8M | |
| Accounts receivable, net of credit loss allowance of $95,494 and $33,039 | $1.1M | $1.4M | |
| Note receivable | $65.2K | ||
| Prepaid expense, deposit and other receivable, net | $1.3M | $222.0K | |
| Inventories, net | $196.6K | $96.5K | |
| Right of return asset | $501.4K | $141.7K | |
| Current assets from discontinued operation | $3.5M | ||
| Total current assets | $11.0M | $10.3M | |
| Property and equipment at cost, net of accumulated depreciation | $191.1K | $160.6K | |
| Intangible assets, net | $280.0K | $365.4K | |
| Right of use operating lease assets, net | $159.2K | $271.3K | |
| Deposit | $4.3K | $38.9K | |
| Non-current assets from discontinued operation | $3.3M | ||
| Total non-current assets | $634.6K | $4.1M | |
| TOTAL ASSETS | $11.7M | $14.4M | |
| Accounts payables | $650.6K | $1.0M | |
| Accrued liabilities and other payables | $2.0M | $1.2M | |
| Current portion of obligations under operating leases | $43.7K | $108.8K | |
| Loan payable, current | $187.8K | $262.9K | |
| Contract liabilities | $72.3K | $15.4K | |
| Income tax payable | $404.9K | $233.1K | |
| Convertible debts - current | $85.1K | $910.7K | |
| Refund liabilities | $849.8K | $77.2K | |
| Current liabilities from discontinued operation | $5.9M | ||
| Total current liabilities | $4.5M | $9.7M | |
| Loan payable, non-current | $46.3K | ||
| Deferred tax liabilities | $83.1K | ||
| Obligations under operating leases, non-current | $115.5K | $150.8K | |
| Non-current liabilities from discontinued operation | $1.7M | ||
| Total non-current liabilities | $161.8K | $1.9M | |
| TOTAL LIABILITIES | $4.6M | $11.6M | |
| Common stocks, $0.0001 par value, 200,000,000 shares authorized, 34,427,559 and 10,500,000 issued and outstanding as of June 30, 2026 and 2025, respectively | $3.4K | $1.1K | |
| Subscription receivable | -$1.4M | ||
| Additional paid-in capital | $22.7M | $8.1M | |
| Statutory reserve | $63.4K | $63.4K | |
| Deficits | -$14.8M | -$5.3M | |
| Accumulated other comprehensive income | $484.8K | $12.3K | |
| Total equity | $7.0M | $2.8M | $639.8K |
| TOTAL LIABILITIES AND EQUITY | $11.7M | $14.4M | |
| Accounts receivable, net of credit loss allowance | $95.5K | $33.0K | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 200.0M shares | 200.0M shares | |
| Common stock, shares issued (in Shares) | 34.4M shares | 10.5M shares | |
| Common stock, shares outstanding (in Shares) | 34.4M shares | 10.5M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Net loss | -$9.5M | -$5.2M |
| Less: Income (Loss) from discontinued operation, net of tax provision | $654.4K | -$3.3M |
| Net loss from continuing operations | -$10.1M | -$1.9M |
| Depreciation | $52.0K | $15.8K |
| Amortization of intangible asset | $85.5K | $53.4K |
| Lease expense of operating lease assets | $94.4K | $80.4K |
| Provision of allowance for expected credit loss on accounts receivable | $58.8K | $32.8K |
| Provision of allowance for expected credit loss on loan receivable | $2.3M | |
| Write-off of supplier advance | 20.0M CNY | |
| Amortized interest expense | $109.8K | $139.0K |
| Accrued interest expense of convertible debt | $10.3K | $39.8K |
| Deferred tax expense | -$82.9K | -$21.6K |
| Interest income | -$268.7K | -$28.1K |
| Stock-based compensation expense for consulting services | $3.3M | |
| Accounts receivable | $279.9K | -$1.4M |
| Note receivables | $66.7K | -$65.2K |
| Inventories | -$91.9K | -$96.5K |
| Right of return asset | -$341.3K | -$141.7K |
| Prepayment, deposit and other receivable | -$2.8M | -$150.9K |
| Accounts payables | -$411.8K | $1.0M |
| Contract liabilities | $54.4K | $15.4K |
| Accrued expense and other payables | $772.1K | $1.5M |
| Due to a related party | $220.2K | |
| Refund liabilities | $745.3K | $77.2K |
| Income tax payable | $154.1K | $233.1K |
| Operating lease liabilities | -$82.5K | -$92.0K |
| Net cash used in operating activities from continuing operations | -$3.2M | -$778.8K |
| Purchase of furniture and equipment | -$2.0K | -$20.4K |
| Payment for leasehold improvement | -$50.7K | |
| Cash payment for assets acquisition | -$552.7K | |
| Cash acquired from assets acquisition | $276.4K | |
| Loan to a third party | -$9.2M | |
| Interest received from loan to third parties | $16.7K | |
| Net cash used in investing activities from continuing operations | -$9.2M | -$330.8K |
| Proceeds from loan borrowing | $162.9K | |
| Repayment of loans | -$23.9K | |
| Net proceeds from issuance of convertible notes | $1.2M | |
| Repayment of principal of convertible debt | -$432.9K | -$296.9K |
| Repayment of equipment and vehicle loans | -$11.7K | |
| Proceeds from initial public offering, net of share issuance costs | $5.4M | |
| Proceeds from a private placement | $8.2M | $3.0M |
| Repayment to shareholders | -$805.9K | |
| Net cash provided by financing activities from continuing operations | $7.8M | $8.6M |
| Operating activities | -$1.4M | -$1.9M |
| Investing activities | -$357.5K | |
| Financing activities | $1.4M | -$415.5K |
| Cash outflow in connection with sales of ABL Chicago | -$167.5K | |
| Net cash used in discontinued operation | -$141.2K | -$2.6M |
| Effect of exchange rate changes on cash | $423.9K | $9.3K |
| Net (decrease) increase in cash | -$4.3M | $4.8M |
| Cash paid for income tax | $18.0K | $2.4K |
| Cash paid for interest | $455.2K | $176.7K |
| Issuance of common shares in exchange for consulting service | $4.4M | |
| Convertible notes converted to common shares | $512.7K | |
| Addition to property and equipment included in loan payable | $69.2K | $102.2K |
| Property disposal through loan payable | $93.8K | |
| Right of use assets obtained in exchange for operating lease obligations | $1.5M | |
| Right of use assets obtained in exchange for finance lease obligation | $89.0K | |
| Additions to property and equipment through accounts payable and other payable | $20.6K | |
| Additions to leasehold improvement through accounts payable and other payable | $84.8K | |
| Due to shareholder offset against loan receivables from a third party | $244.0K | |
| Due to shareholder offset against loan receivables related parties | $311.2K |
No quarter-by-quarter statement was filed.
Corporate structure
Quanome Technologies, Inc. sits at the top of its group. 8 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Quanome Technologies, Inc.
- Brink Holding Ltd Filed SCHEDULE 13G/A on Quanome Technologies, Inc., latest May 4, 2026 (2 filings since Nov 10, 2025)
- Henry Liu Filed SC 13G on Quanome Technologies, Inc., latest Oct 24, 2024
- Shuai Li Filed SC 13G on Quanome Technologies, Inc., latest Oct 24, 2024
- Quanome Technologies, Inc. Itasca, Illinois
- Quantum Nexus Technologies Ltd. Subsidiary · Cayman Islands
- Smart Reserve Holding LTD Subsidiary · Cayman Islands
- Smart Reserve Inc Subsidiary · Cayman Islands
- XDT Infrastructure I, LLC Subsidiary · Delaware, United States
- XDT Infrastructure II, LLC Subsidiary · Delaware, United States
- XDT US HoldCo,LLC Subsidiary · Delaware, United States
- XDT, Inc. Subsidiary · Delaware, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Quanome Technologies, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $261.5K2 Jun 30, 2026 | $176.5K2 Jun 30, 2025 | +48.1% |
| Accumulated depreciation | $70.4K2 Jun 30, 2026 | $15.9K2 Jun 30, 2025 | +342.3% |
| Property and equipment, net | $191.1K2 Jun 30, 2026 | $160.6K2 Jun 30, 2025 | +19.0% |
| Finance-lease assets | $93.8K6 Jun 30, 2025 | $37.5K6 Jun 30, 2024 | +150.3% |
| Operating-lease assets (leased space) | $159.2K2 Jun 30, 2026 | $271.3K2 Jun 30, 2025 | −41.3% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $670.3K2 Jun 30, 2026 | $4.8M2 Jun 30, 2025 | −86.1% |
| Long-term investments | $15.7K6 Jun 30, 2025 | $15.7K6 Jun 30, 2024 | 0% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $280.0K2 Jun 30, 2026 | $365.4K2 Jun 30, 2025 | −23.4% |
| Finite-lived intangibles, gross | $418.9K2 Jun 30, 2026 | $418.9K2 Jun 30, 2025 | 0% |
| Accumulated amortization | $138.9K2 Jun 30, 2026 | $53.4K2 Jun 30, 2025 | +160.0% |
| Finite-lived intangibles, net | $365.4K6 Jun 30, 2025 |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $196.6K2 Jun 30, 2026 | $96.5K2 Jun 30, 2025 | +103.7% |
| Finished goods | $196.6K2 Jun 30, 2026 | $96.5K2 Jun 30, 2025 | +103.7% |
Properties, in its own words
We lease two premises with a gross floor area of approximately 599 square meters in Wuhan, Hubei Province, China, for the daily business activities and office use of our pharmaceutical distribution and supply chain service, with lease terms from January 1, 2025 to December 31, 2029, and from March 22, 2026 to March 21, 2027, respectively. Our executive office is located at 112W 34th St, FL 18, Room 18022, New York, NY 10120 with lease terms from September 1, 2026 to August 31, 2027.
We may add additional offices as we expand our business to other states and countries. We believe that our facilities are sufficient for our current needs and that, should it be needed, additional facilities will be available to accommodate the expansion of our business.
Item 2 of the 10-K filed Sep 25, 2026.5
Leadership
Who has led Quanome Technologies, Inc., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerHenry Liu Jul 19, 2024 to Jul 19, 202411
- Chief financial officerLong Yi Jul 19, 2024 to Jul 19, 202412
Board members and other officers (5)
- Board memberAik Siang Goh Nov 18, 2025 to now13
- Board memberYiye Zhou Jul 16, 2024 to Jul 16, 202414
- Board memberZhengyi Fang Jul 16, 2024 to Jul 16, 202415
- Board memberCynthia Vuong Jul 17, 2024 to Jul 17, 202416
- Board memberHenry Liu Jul 19, 2024 to Jul 19, 202411
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Quantum Nexus Technologies Ltd. Cayman Islands4
- Smart Reserve Holding LTD Cayman Islands4
- Smart Reserve Inc Cayman Islands4
- XDT Infrastructure I, LLC Delaware4
- XDT Infrastructure II, LLC Delaware4
- XDT US HoldCo,LLC Delaware4
- XDT, Inc. Delaware4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Lakeside Holding LtdOct 30, 2023 to Jul 10, 20263
Timeline
- Oct 9, 20268-K Regulation FD disclosure17
- Oct 5, 20268-K Entered a material agreement18
- Oct 1, 20268-K Entered a material agreement; New debt or obligation; Regulation FD disclosure19
- Sep 25, 20268-K Regulation FD disclosure20
- Sep 23, 20268-K Regulation FD disclosure21
- Sep 21, 20268-K Entered a material agreement22
- Sep 21, 20268-K Executive or director change23
- Aug 20, 20268-K Regulation FD disclosure24
- Aug 5, 20268-K Regulation FD disclosure25
- Aug 4, 20268-K Bylaws or fiscal year changed26
- Jul 10, 20268-K Listing notice or transfer27
- Jul 7, 20268-K Bylaws or fiscal year changed28
- Jul 19, 2024New chief executive Henry Liu becomes CEO11
Calendar
Coming up
- Nov 18, 2026Reports results for the quarter ending Sep/202629
When it reported results
- May 15, 2025Reported quarterly or annual results30
- Feb 14, 2025Reported quarterly or annual results31
- Nov 15, 2024Reported quarterly or annual results32
- Oct 1, 2024Reported quarterly or annual results33
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
119 filings to the SEC since October 2021: 3 annual reports, 6 quarterly reports, 40 major events, 12 insider forms, 4 large holders, 54 other. The latest 20:
- Oct 9, 20268-K CURRENT REPORT EDGAR
- Oct 5, 20268-K CURRENT REPORT EDGAR
- Oct 1, 20268-K CURRENT REPORT EDGAR
- Oct 1, 2026S-8 REGISTRATION STATEMENT EDGAR
- Oct 1, 2026S-3/A AMENDMENT NO. 3 TO FORM S-3 EDGAR
- Sep 25, 202610-K ANNUAL REPORT EDGAR
- Sep 25, 20268-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
- Sep 23, 20268-K CURRENT REPORT EDGAR
- Sep 22, 20263 EDGAR
- Sep 21, 20268-K CURRENT REPORT EDGAR
- Sep 21, 20268-K CURRENT REPORT EDGAR
- Sep 2, 2026S-3/A AMENDMENT NO. 2 TO FORM S-3 EDGAR
- Aug 20, 20268-K CURRENT REPORT EDGAR
- Aug 5, 20268-K CURRENT REPORT EDGAR
- Aug 5, 2026S-3/A AMENDMENT NO. 1 TO FORM S-3 EDGAR
- Aug 4, 20268-K CURRENT REPORT EDGAR
- Jul 10, 20268-K CURRENT REPORT EDGAR
- Jul 8, 2026S-3 REGISTRATION STATEMENT EDGAR
- Jul 7, 20268-K CURRENT REPORT EDGAR
- Jun 5, 20268-K CURRENT REPORT EDGAR
The 119 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Brink Holding LtdSCHEDULE 13G/A, 2 filings Nov 10, 2025 to May 4, 202634
- Henry LiuSC 13G, 1 filing Oct 24, 202435
- Shuai LiSC 13G, 1 filing Oct 24, 202436
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 295,675 | $128.3K | 0.0% | No change |
| Geode Capital Management, LLC | 170,411 | $74.0K | 0.0% | −1,740 |
| Vanguard Fiduciary Trust Co | 135,121 | $58.6K | 0.0% | No change |
| Northern Trust Corp | 32,690 | $14.2K | 0.0% | No change |
| UBS Group AG | 3,005 | $1.3K | 0.0% | +1,920 |
| Tower Research Capital LLC (TRC) | 2,939 | $1.3K | 0.0% | New |
| Virtu Financial LLC | 10,410 | $5 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Quanome Technologies, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARQuanome Technologies, Inc.1
- CIK0001996192
- Employer ID (EIN)82-19784915
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inNevada5
- Fiscal year endsJune 301
- Industry code (SIC)4731 Arrangement of Transportation of Freight & Cargo1
- SEC reviewing officeOffice of Energy & Transportation, Division of Corporation Finance1
- Business address1475 Thorndale Ave Suite A, Itasca, IL 601431
- Phone(312) 709-84501
- Shares outstanding34,427,559 shares as of Sep 22, 20265
- Public float$30.6M as of Dec 31, 20255
- AuditorZH CPA, LLC, Denver, Colorado PCAOB ID 6413; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceOct 30, 20231
- Filings119 in all: 8-K (38), CORRESP (12), 3 (11), 10-Q (6), S-1/A (5), UPLOAD (5), 10-K (3), DEF 14A (3)1
All 32 form types
DRSLTR (3), NT 10-Q (3), S-3/A (3), 8-K/A (2), DRS/A (2), EFFECT (2), PRE 14A (2), S-1 (2), SC 13G (2), 3/A (1), 424B3 (1), 424B4 (1), 8-A12B (1), CERT (1), DEF 14C (1), DRS (1), NT 10-K (1), PRE 14C (1), PRER14A (1), S-1MEF (1), S-3 (1), S-8 (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (10-K) Sep 25, 2026
Quarterly report (10-Q) May 19, 2026
Proxy statement (DEF 14A) Jan 30, 2026
Latest 8-K (8-K) Oct 9, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value US$0.0001 per share | QNME | The Nasdaq Stock Market LLC |
From the cover page of the 10-K filed Sep 25, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks Quanome Technologies, Inc. names in Item 1A of its 10-K filed Sep 25, 2026: 36 risks under these headings, as written.5
- Risks Related to Our Business and Development
- Our pharmaceutical distribution business depends on our relationships with manufacturers, suppliers and other business partners and our ability to maintain an adequate supply of products.
- We face competition and changes in customer demand, procurement practices and pricing that could adversely affect our revenue and profitability.
- We may not be successful in expanding into new business areas or markets, and such expansion may expose us to additional operational, regulatory and execution risks.
- Our long-term growth and competitiveness are highly dependent on our ability to control costs.
- Any failure to obtain or maintain requisite approvals, licenses, permits or other regulatory authorizations applicable to our business could materially adversely affect our business, financial condition and results of operations.
- Failure to renew our current leases or locate desirable premises for our facilities, or challenges on the use of certain leased properties by us or our service providers, could materially and adversely affect our business, financial condition and results of operations.
- None of our service agreements with our customers is on an exclusive basis.
- We may be subject to potential liability in connection with pending or threatened legal proceedings and other matters, which could adversely affect our business, financial condition or results of operations.
- Our newly launched AI compute and managed inference business is at an early stage and may not develop as expected.
- Our ability to provide AI compute services depends on the availability, performance and cost of specialized computing infrastructure.
- Interruptions, failures or security incidents affecting our infrastructure or service providers could disrupt our operations.
The other 25 risks
- We may depend on third-party technology, software, models and infrastructure that we do not control.
- Our use and deployment of customer-selected artificial intelligence models may expose us to intellectual property, licensing and other legal risks.
- Our business may be subject to evolving export control, sanctions, data protection, cybersecurity and other regulatory requirements, which could restrict our ability to provide AI computing services to certain customers or in certain jurisdictions.
- Rapid technological change could impair the value of our infrastructure and require significant additional investment.
- Our emerging quantum- and certain other advanced technology activities may become subject to an evolving and potentially complex regulatory framework, which could increase our costs or restrict our activities.
- We are subject to anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws, and non-compliance with such laws could adversely affect our business, results of operations, financial condition and reputation.
- If we fail to implement and maintain effective internal control over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of our common stock may be materially and adversely affected.
- Our insurance coverage may not be sufficient, which could expose us to significant costs and business disruptions.
- Risks Related to Our Business Operations in the PRC
- The PRC government may exert significant influence over our PRC subsidiaries’ operations, which could result in a material change in our operations and/or in the value of the securities we are registering, and could cause the value of our securities to significantly decline or become worthless.
- Changes in political, economic and other policies of the PRC government could have a material adverse effect on the overall economic growth of the PRC, which could reduce the demand for products offered by Hupan Pharmaceutical, and therefore adversely affect our financial results.
- There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations.
- Failure to obtain, renew or maintain the licenses, permits and filings required for our business operations, or to comply with the conditions and scope limitations attached to them, could materially and adversely affect our business, financial condition and results of operations.
- Restrictions on the ability of our PRC subsidiaries to make dividends and other distributions to us could limit our ability to fund our operations and make distributions to shareholders.
- PRC regulation of loans to and direct investment in PRC entities by offshore holding companies may restrict or delay us from using the proceeds of future offerings to make loans or additional capital contributions to our PRC subsidiaries, which may adversely affect our liquidity and our ability to fund and expand our business.
- Regulatory restrictions on currency conversion may limit our ability to utilize our revenues effectively and affect the value of your investment.
- Implementation of the labor laws and regulations in the PRC may adversely affect our business and results of operations, and failure to fully comply with PRC labor-related laws may expose us to potential liabilities and penalties.
- Fluctuations in exchange rates may result in foreign currency exchange losses.
- Changes in the relations between the PRC and the United States may affect our business, financial condition and results of operations.
- You may experience difficulties in effecting service of legal process upon, enforcing foreign judgments against, or bringing original actions in the PRC against us or certain of our directors and officers, and your ability to protect your interests through the U.S. courts may be limited.
- We may be required to complete filing procedures with the CSRC in connection with future offerings of our securities under this registration statement, and we cannot assure you that we will be able to complete such filings in a timely manner or at all.
- Compliance with the PRC’s laws, regulations and guidelines relating to data security, cybersecurity and privacy and any other future laws and regulations may entail significant expenses and could affect our business.
- The enacted “Holding Foreign Companies Accountable Act” and the “Accelerating Holding Foreign Companies Accountable Act” call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors. These developments could add uncertainties to the market for our common stock.
- Risks Related to Our Securities
- If we are unable to regain and maintain compliance with Nasdaq listing standards, our common stock could be delisted, which could adversely affect the liquidity of our common stock and our ability to raise capital.
- If you purchase our securities, you may experience future dilution as a result of future equity offerings or other prior equity issuances.
- The market price of our common stock and the trading volume of our common stock have been and may continue to be volatile, and such volatility could cause the market price of our common stock to decrease.
Legal proceedings
From time to time, we may be subject to legal proceedings, investigations and claims incidental to the conduct of our business. We are currently not a party to, nor are we aware of, any legal proceedings, investigations or claims which, in the opinion of our management, are likely to have a material adverse effect on our business, financial condition or results of operations.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARHenry Liu, Chief executive officer
- 12SEC EDGARLong Yi, Chief financial officer
- 13SEC EDGARAik Siang Goh, Board member
- 14SEC EDGARYiye Zhou, Board member
- 15SEC EDGARZhengyi Fang, Board member
- 16SEC EDGARCynthia Vuong, Board member
- 17SEC EDGARRegulation FD disclosure
- 18SEC EDGAREntered a material agreement
- 19
- 20SEC EDGARRegulation FD disclosure
- 21SEC EDGARRegulation FD disclosure
- 22SEC EDGAREntered a material agreement
- 23SEC EDGARExecutive or director change
- 24SEC EDGARRegulation FD disclosure
- 25SEC EDGARRegulation FD disclosure
- 26SEC EDGARBylaws or fiscal year changed
- 27SEC EDGARListing notice or transfer
- 28SEC EDGARBylaws or fiscal year changed
- 29NasdaqNasdaq calendar
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37